The Details: Tevogen said it will gain unparalleled access to Microsoft’s ecosystem through the partnership, which the company believes will accelerate and streamline its algorithm development.
The acceleration is expected to enable Tevogen to more rapidly achieve its mission of reducing drug development costs, expediting drug discovery and delivering life-altering therapies to large patient populations.
“The partnership with Microsoft, the leading innovator in the AI space, is a substantial investment in Tevogen’s goal to provide affordable and accessible therapies. By leveraging Microsoft’s cutting-edge AI technology, Tevogen aims to push the boundaries of what AI can achieve in the biotech industry,” the company said.
Mittul Mehta, CIO and Head of Tevogen AI, noted that Generative AI could generate between $60 billion and $110 billion annually in economic value for pharmaceutical and medtech companies, citing The McKinsey Global Institute.
“The metrics are astounding, and we are excited to contribute to that economic value,” Mehta said.
How To Buy Tevogen Bio Shares
By now you're likely curious about how to participate in the market for Tevogen Bio Holdings – be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share.
In the case of Tevogen Bio Holdings, which is trading at $2.8 as of publishing time, $100 would buy you 35.71 shares of stock.
TVGN Price Action: Tevogen shares were up 60.3% at $2.58 at the time of writing, per data from Benzinga Pro.
Image: Image: Unsplash/ Volodymyr Hryshchenko
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
